Patil Chirag G, Veeravagu Anand, Bower Regina S, Li Gordon, Chang Steven D, Lim Michael, Adler John R
Department of Neurosurgery, Stanford University School of Medicine, Stanford, California 94305-5327, USA.
Neurosurg Focus. 2007;23(6):E9. doi: 10.3171/FOC-07/12/E9.
Patients with atypical trigeminal neuralgia (TN) have unilateral pain in the trigeminal distribution that is dull, aching, or burning in nature and is constant or nearly constant. Studies of most radiosurgical and surgical series have shown lower response rates in patients with atypical TN. This study represents the first report of the treatment of atypical TN with frameless CyberKnife stereotactic radiosurgery (SRS).
Between 2002 and 2007, 7 patients that satisfied the criteria for atypical TN and underwent SRS were included in our study. A 6-8-mm segment of the trigeminal nerve was targeted, excluding the proximal 3 mm at the brainstem. All patients were treated in a single session with a median maximum dose of 78 Gy and a median marginal dose of 64 Gy.
Outcomes in 7 patients with a mean age of 61.6 years and a median follow-up of 20 months are reported. Following SRS, 4 patients had complete pain relief, 2 had minimal pain relief with some decrease in the intensity of their pain, and 1 patient experienced no pain relief. Pain relief was reported within 1 week of SRS in 4 patients and at 4 months in 2 patients. After a median follow-up of 28 months, pain did not recur in any of the 4 patients who had reported complete pain relief. Complications after SRS included bothersome numbness in 3 patients and significant dysesthesias in 1 patient.
The authors have previously reported a 90% rate of excellent pain relief in patients with classic TN treated with CyberKnife SRS. Compared with patients with classic TN, patients with atypical TN have a lower rate of pain relief. Nevertheless, the nearly 60% rate of success after SRS achieved in this study is still comparable to or better than results achieved with any other treatment modality for atypical TN.
非典型三叉神经痛(TN)患者三叉神经分布区域出现单侧疼痛,性质为钝痛、酸痛或灼痛,且持续或几乎持续存在。大多数放射外科和外科系列研究表明,非典型TN患者的缓解率较低。本研究是关于使用无框架射波刀立体定向放射外科治疗(SRS)非典型TN的首次报告。
2002年至2007年期间,7例符合非典型TN标准并接受SRS治疗的患者纳入本研究。三叉神经6 - 8毫米节段作为靶点,脑干近端3毫米除外。所有患者均单次接受治疗,最大剂量中位数为78 Gy,边缘剂量中位数为64 Gy。
报告了7例平均年龄61.6岁、中位随访时间20个月患者的结果。SRS治疗后,4例患者疼痛完全缓解,2例患者疼痛略有缓解,疼痛强度有所降低,1例患者疼痛未缓解。4例患者在SRS后1周内报告疼痛缓解,2例患者在4个月时报告疼痛缓解。中位随访28个月后,4例报告疼痛完全缓解的患者均未复发疼痛。SRS后的并发症包括3例患者出现烦人的麻木感,1例患者出现明显的感觉异常。
作者之前报告使用射波刀SRS治疗的典型TN患者疼痛缓解优良率为90%。与典型TN患者相比,非典型TN患者的疼痛缓解率较低。尽管如此,本研究中SRS后近60%的成功率仍与非典型TN的任何其他治疗方式所取得的结果相当或更好。